ELII: Multi-pathogen antiviral medical countermeasure deploying FDA approved drug against Orthopoxvirus

Project: Research project

Project Details

StatusFinished
Effective start/end date2/24/14 → 10/31/15

Funding

  • Inhibikase Therapeautics, Inc: $1,011,169.00